VANGUARD GROUP INC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 35 filers reported holding PSYCHEMEDICS CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$997,069
-11.6%
251,151
+1.5%
0.00%
Q2 2023$1,128,317
-13.1%
247,4380.0%0.00%
Q1 2023$1,299,050
+7.0%
247,4380.0%0.00%
Q4 2022$1,213,609
-23.9%
247,438
+0.0%
0.00%
Q3 2022$1,595,000
+1.7%
247,3400.0%0.00%
Q2 2022$1,568,000
-8.1%
247,3400.0%0.00%
Q1 2022$1,707,000
-1.7%
247,3400.0%0.00%
Q4 2021$1,736,000
-16.5%
247,340
-0.1%
0.00%
Q3 2021$2,080,000
+20.2%
247,622
-0.4%
0.00%
Q2 2021$1,731,000
+12.3%
248,7000.0%0.00%
Q1 2021$1,542,000
+19.5%
248,700
-1.9%
0.00%
Q4 2020$1,290,000
+15.4%
253,5210.0%0.00%
Q3 2020$1,118,000
-20.6%
253,5210.0%0.00%
Q2 2020$1,408,000
-8.2%
253,5210.0%0.00%
Q1 2020$1,534,000
-33.9%
253,5210.0%0.00%
Q4 2019$2,320,000
+0.4%
253,5210.0%0.00%
Q3 2019$2,310,000
-3.3%
253,521
+7.0%
0.00%
Q2 2019$2,390,000
-23.6%
236,833
+6.2%
0.00%
Q1 2019$3,129,000
-11.0%
223,031
+0.7%
0.00%
Q4 2018$3,516,000
-15.6%
221,5310.0%0.00%
Q3 2018$4,167,000
-2.3%
221,5310.0%0.00%
Q2 2018$4,263,000
-6.9%
221,5310.0%0.00%
Q1 2018$4,581,000
+0.6%
221,5310.0%0.00%
Q4 2017$4,555,000
+12.8%
221,531
+1.1%
0.00%
Q3 2017$4,039,000
-26.1%
219,1690.0%0.00%
Q2 2017$5,468,000
+28.7%
219,169
+3.5%
0.00%
Q1 2017$4,247,000
-18.4%
211,817
+0.4%
0.00%
Q4 2016$5,206,000
+21.1%
210,917
-2.6%
0.00%
Q3 2016$4,298,000
+41.7%
216,615
-1.9%
0.00%
Q2 2016$3,033,000
-10.8%
220,735
-10.8%
0.00%
Q1 2016$3,402,000
+36.4%
247,395
+0.5%
0.00%
Q4 2015$2,495,000
+1.8%
246,095
+1.2%
0.00%
Q3 2015$2,450,000
-31.9%
243,295
+0.3%
0.00%
Q2 2015$3,596,000
-9.7%
242,507
+1.1%
0.00%
Q1 2015$3,983,000
+10.6%
239,937
+0.4%
0.00%
Q4 2014$3,601,000
+5.9%
238,937
+0.0%
0.00%
Q3 2014$3,399,000
+0.5%
238,8370.0%0.00%
Q2 2014$3,382,000
-17.3%
238,8370.0%0.00%
Q1 2014$4,091,000
+17.5%
238,837
+0.7%
0.00%
Q4 2013$3,483,000
+10.9%
237,1020.0%0.00%
Q3 2013$3,142,000
+22.9%
237,102
-0.4%
0.00%
Q2 2013$2,557,000238,1020.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 40,001$276,0000.13%
SANTA MONICA PARTNERS LP 20,000$138,0000.10%
Invenomic Capital Management LP 135,631$769,0000.08%
Cannell Capital 78,306$540,0000.08%
RBF Capital, LLC 144,231$996,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 266,502$1,839,0000.04%
Ancora Advisors LLC 80,728$557,0000.01%
HighMark Wealth Management LLC 2,039$14,0000.01%
Renaissance Technologies 341,422$2,356,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 34,618$240,0000.00%
View complete list of PSYCHEMEDICS CORP shareholders